share_log

ODAIA to Showcase the Impact of AI in Pharma at Upcoming Industry Events

ODAIA to Showcase the Impact of AI in Pharma at Upcoming Industry Events

ODAIA将在即将举行的行业活动中展示人工智能对制药的影响
PR Newswire ·  04/23 07:05

TORONTO, April 23, 2024 /PRNewswire/ -- Pharma experts and AI innovators from ODAIA will be the featured presenters at top industry events this spring. Speakers will share how pharma companies are advancing their commercial strategies using Customer Science, a transformative discipline that integrates AI with data science and behavioral science for a deeper understanding of healthcare professionals (HCPs) and what motivates their patient decisions.

多伦多,2024 年 4 月 23 日 /PRNewswire/ — 来自多伦多的制药专家和人工智能创新者 奥达亚 将成为今年春季顶级行业活动的特邀主持人。演讲者将分享制药公司如何使用以下方法推进其商业战略 客户科学,这是一门变革性学科,将人工智能与数据科学和行为科学相结合,旨在加深对医疗保健专业人员(HCP)及其患者决策动机的理解。

Veeva Commercial Summit, Boston, May 8, at 12:30 p.m. EST

Veeva 商业峰会,波士顿,美国东部标准时间5月8日下午 12:30

Philip Poulidis, CEO, will demonstrate the use of AI to find, select, and engage the right HCPs. It typically takes months for marketing to complete customer segmentation and targeting, which is refreshed once or twice a year. When there's a marketplace change, an entirely new data analysis must be done, taking more months before sales gets updated plans of action to start engaging HCPs.

首席执行官菲利普·普利迪斯,将演示如何使用人工智能来查找、选择和聘用合适的 HCP。营销部门通常需要几个月的时间才能完成客户细分和定位,每年更新一次或两次。当市场发生变化时,必须进行全新的数据分析,再过几个月,销售人员才能更新行动计划,开始与HCP合作。

Poulidis will show ODAIA MAPTUAL completing this process in minutes, not months. Marketing can set new brand objectives, use advanced AI capabilities to automate data analysis, and deliver personalized GenAI-powered insights in Veeva CRM MyInsights. Sales reps can prioritize which HCPs to contact, how best to engage them, and get treatments to patients months faster.

Poulidis 将露面 奥达亚马耳他人 在几分钟而不是几个月内完成此过程。营销可以设定新的品牌目标,使用先进的人工智能功能来自动进行数据分析,并在以下方面提供基于Genai的个性化见解 Veeva CRM 我的见解。销售代表可以优先联系哪些 HCP,如何最好地与他们互动,并缩短数月为患者提供治疗。

PMSA 2024 Annual Conference, Denver, Colo., May 8, at 11:10 a.m. EST

PMSA 2024 年年会,科罗拉多州丹佛,美国东部标准时间5月8日上午11点10分

Matthieu Buot de l'Epine, lead machine learning engineer, and Pouyan Jahangiri, director of data science and machine learning, will discuss improving prediction accuracy in prescription modeling using hierarchical machine learning techniques and time series data. Creating accurate and consistent forecasts at the individual HCP, territory, state, and national levels is critical in the pharma industry because of the limited shelf life for medicines and significant impact of prediction errors to resource allocations, financial planning, and regulatory compliance.

Matthieu Buot de l'Epine,首席机器学习工程师,以及 数据科学和机器学习总监 Pouyan Jahangiri,将讨论使用分层机器学习技术和时间序列数据提高处方建模的预测准确性。由于药品的保质期有限,而且预测错误会对资源分配、财务规划和监管合规性产生重大影响,因此在个别HCP、地区、州和国家层面创建准确和一致的预测对于制药行业至关重要。

Buot de l'Epine and Jahangiri will discuss how a hierarchical model enables simultaneous predictions and outputs at every level and integrates insights for better consistency and accuracy in forecasting, supporting pharma companies in planning and executing their commercial strategies more efficiently and effectively.

Buot de l'Epine和Jahangiri将讨论分层模型如何实现各个层面的同步预测和输出,如何整合见解,以提高预测的一致性和准确性,支持制药公司更高效地规划和执行其商业战略。

Reimagine Pharma Marketing, Long Branch, N.J., May 21, at 1:45 p.m. EST

重新构想药品营销,新泽西州朗布兰奇,美国东部标准时间5月21日下午 1:45

Eric Trépanier, chief strategy and customer officer, will be joined on stage with a top 10 pharma customer to discuss the use of AI to provide never-before-seen insights into HCPs and dramatically improve marketing and sales rep decision-making. Traditional approaches like next best action and segmentation and targeting fall short in delivering meaningful customer experiences.

埃里克·特雷帕尼尔,首席战略和客户官,将与排名前十的制药客户一起登台,讨论如何使用人工智能为HCP提供前所未有的见解,并显著改善营销和销售代表的决策。次佳行动、细分和定位等传统方法不足以提供有意义的客户体验。

Speakers will share how commercial pharma innovators are embracing Customer Science to better understand HCPs and drive engagement. Commercial organizations can break the limitations of rules-based systems and historical data analysis to deliver valued HCP experiences using real-time, relevant insights.

演讲者将分享商业制药创新者如何利用客户科学来更好地了解HCP并提高参与度。商业组织可以打破基于规则的系统和历史数据分析的局限性,使用实时、相关的见解提供有价值的 HCP 体验。

Snowflake Data Cloud Summit 24, San Francisco Calif., June 5, at 3:30 p.m. PST

Snowflake 数据云峰会 24,加利福尼亚州旧金山,太平洋标准时间6月5日下午 3:30

Phillip Poulidis, CEO, and Zak Beharie, CTO, will discuss the successful deployment of machine learning applications for commercial use cases in pharma. The process for transferring data includes cumbersome secure file transfer protocols (SFTPs), slow computing power, and complex data agreements.

首席执行官菲利普·普利迪斯和 首席技术官 Zak Beharie,将讨论在制药业商业用例中成功部署机器学习应用程序。传输数据的过程包括繁琐的安全文件传输协议 (SFTP)、缓慢的计算能力和复杂的数据协议。

Poulidis and Beharie will share how to overcome data transfer limitations using the Snowflake Native App Framework, ODAIA machine learning, and pharma customers' proprietary data to achieve better ROI. Customers retain total data control, streamline their commercial processes, and seamlessly deliver predictive insights to their commercial organization.

Poulidis 和 Beharie 将分享如何使用以下方法克服数据传输限制 Snowflake 原生应用程序框架、ODAIA 机器学习和制药客户的专有数据,以实现更高的投资回报率。客户保留全面的数据控制权,简化商业流程,并无缝地向其商业组织提供预测性见解。

To learn more about ODAIA, schedule a meeting with our team at Veeva Summit, PMSA, Reimagine, and Snowflake Data Cloud Summit. Learn more about all our upcoming events here.

要了解有关 ODAIA 的更多信息,请安排与我们的团队会面 Veeva 峰会PMSA重新构想,以及 Snowflake 数据云峰会。了解有关我们所有内容的更多信息 即将举行的活动在这里

About ODAIA
ODAIA is the leading AI company helping life sciences companies innovate their commercial strategies using Customer Science. The company's cloud solution, MAPTUAL, integrates data science, behavioral science, and AI to gain a deep understanding of healthcare professionals (HCPs) and their patient decisions across the entire customer journey. To learn more about ODAIA, visit our website or follow us on LinkedIn.

关于 ODAIA
ODAIA是领先的人工智能公司,帮助生命科学公司利用客户科学创新其商业策略。该公司的云解决方案MAPTUAL集成了数据科学、行为科学和人工智能,以深入了解医疗保健专业人员(HCP)及其在整个客户旅程中的患者决策。要了解有关 ODAIA 的更多信息,请访问 我们的网站 或者关注我们 领英

SOURCE ODAIA

来源 ODAIA

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发